Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide.

Gastroesophageal acid reflux into the airways can trigger asthma attacks. Indeed, citric acid inhalation causes bronchoconstriction in guinea pigs, but the mechanism of this effect has not been fully clarified. We investigated the role of tachykinins, bradykinin, and nitric oxide (NO) on the citric acid- induced bronchoconstriction in anesthetized and artificially ventilated guinea pigs. Citric acid inhalation (2-20 breaths) caused a dose-dependent increase in total pulmonary resistance (RL). RL value obtained after 10 breaths of citric acid inhalation was not significantly different from the value obtained after 20 breaths (p = 0.22). The effect produced by a half-submaximum dose of citric acid (5 breaths) was halved by the bradykinin B2 receptor antagonist HOE 140 (0.1 micromol x kg-1, intravenous) and abolished by the tachykinin NK2 receptor antagonist SR 48968 (0.3 micromol x kg-1, intravenous). Bronchoconstriction induced by a submaximum dose of citric acid (10 breaths) was partially reduced by the administration of HOE 140, SR 48968, or the NK1 receptor antagonist CP-99,994 (8 micromol x kg-1, intravenous) alone and completely abolished by the combination of SR 48968 and CP-99,994. Pretreatment with the NO synthase inhibitor, L-NMMA (1 mM, 10 breaths every 5 min for 30 min) increased in an L-arginine-dependent manner the effect of citric acid inhalation on RL. HOE 140 and CP-99,994 markedly reduced the L-NMMA-potentiated bronchoconstriction to inhaled citric acid. We conclude that citric acid-induced bronchoconstriction is caused by tachykinin release from sensory nerves, which, in part, is mediated by endogenously released bradykinin. Simultaneous release of NO by citric acid inhalation counteracts tachykinin-mediated bronchoconstriction. Our study suggests a possible implication of these mechanisms in asthma associated with gastroesophageal acid reflux and a potential therapeutic role of tachykinin and bradykinin antagonists.

[1]  P. Black,et al.  Nitric oxide and response to inhaled bradykinin in severe asthma , 1998, The Lancet.

[2]  J. Nadel,et al.  Endogenous nitric oxide inhibits bronchoconstriction induced by cold-air inhalation in guinea pigs: role of kinins. , 1998, American journal of respiratory and critical care medicine.

[3]  D. Julius,et al.  The capsaicin receptor: a heat-activated ion channel in the pain pathway , 1997, Nature.

[4]  J. Nadel,et al.  Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma , 1996, The Lancet.

[5]  C. Bertrand,et al.  Tachykinin and kinin receptor antagonists: therapeutic perspectives in allergic airway disease. , 1996, Trends in pharmacological sciences.

[6]  C. Advenier,et al.  The tachykinin NK2 receptor antagonist SR 48968 inhibits citric acid-induced airway hyperresponsiveness in guinea pigs. , 1996, American journal of respiratory and critical care medicine.

[7]  G. Folkerts,et al.  Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide. , 1996, American journal of respiratory and critical care medicine.

[8]  C. Bertrand,et al.  Evidence that tachykinins relax the guinea‐pig trachea via nitric oxide release and by stimulation of a septide‐insensitive NK1 receptor , 1996, British journal of pharmacology.

[9]  P. Geppetti,et al.  Involvement of tachykinins in plasma extravasation induced by bradykinin and low pH medium in the guinea‐pig conjunctiva , 1995, British journal of pharmacology.

[10]  W. Simpson.  Gastroesophageal reflux disease and asthma. Diagnosis and management. , 1995, Archives of internal medicine.

[11]  S. Bevan,et al.  Protons: small stimulants of capsaicin-sensitive sensory nerves , 1994, Trends in Neurosciences.

[12]  J. Nadel,et al.  Evidence for reduction of bradykinin‐induced bronchoconstriction in guinea‐pigs by release of nitric oxide , 1994, British journal of pharmacology.

[13]  P. Holzer,et al.  Role of bradykinin in the hyperaemia following acid challenge of the rat gastric mucosa , 1994, British journal of pharmacology.

[14]  G. Folkerts,et al.  Nitric oxide and bronchial reactivity , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[15]  C. Bertrand,et al.  Role of kinins in anaphylactic‐induced bronchoconstriction mediated by tachykinins in guinea‐pigs , 1994, British journal of pharmacology.

[16]  C. Bertrand,et al.  Role of kinins in the vascular extravasation evoked by antigen and mediated by tachykinins in guinea pig trachea. , 1993, Journal of immunology.

[17]  P. Barnes,et al.  Nitric oxide and lung disease. , 1993, Thorax.

[18]  C. Bertrand,et al.  Capsaicin increases airflow resistance in guinea pigs in vivo by activating both NK2 and NK1 tachykinin receptors. , 1993, The American review of respiratory disease.

[19]  A. Ganong,et al.  Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor. , 1993, The Journal of pharmacology and experimental therapeutics.

[20]  J. Lundberg,et al.  Inhibitory effects of capsazepine and SR 48968 on citric acid-induced bronchoconstriction in guinea-pigs. , 1993, European journal of pharmacology.

[21]  P. Barnes,et al.  Regulation of NANC neural bronchoconstriction in vivo in the guinea‐pig: involvement of nitric oxide, vasoactive intestinal peptide and soluble guanylyl cyclase , 1993, British journal of pharmacology.

[22]  H P Rang,et al.  Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin , 1992, British journal of pharmacology.

[23]  K. Bhoola,et al.  Bioregulation of kinins: kallikreins, kininogens, and kininases. , 1992, Pharmacological reviews.

[24]  E. Naline,et al.  A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. , 1992, Life sciences.

[25]  C. Maggi,et al.  Low pH-induced release of calcitonin gene-related peptide from capsaicin-sensitive sensory nerves: Mechanism of action and biological response , 1991, Neuroscience.

[26]  J. Solway,et al.  Sensory neuropeptides and airway function. , 1991, Journal of applied physiology.

[27]  P. Holzer.  Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. , 1991, Pharmacological reviews.

[28]  W. König,et al.  Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studies , 1991, British journal of pharmacology.

[29]  M. Rand,et al.  Evidence that part of the NANC relaxant response of guinea‐pig trachea to electrical field stimulation is mediated by nitric oxide , 1991, British journal of pharmacology.

[30]  P. Barnes,et al.  Bradykinin-induced bronchoconstriction in guinea pig in vivo: role of neural mechanisms. , 1990, The Journal of pharmacology and experimental therapeutics.

[31]  J. Nadel,et al.  Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstriction in vivo. , 1988, Journal of applied physiology.

[32]  J. Lundberg,et al.  Capsaicin Sensitive Afferents Contribute to Acute Airway Edema following Tracheal Instillation of Hydrochloric Acid or Gastric Juice in the Rat , 1988, Anesthesiology.

[33]  E. Theodorsson,et al.  Cough and bronchoconstriction mediated by capsaicin-sensitive sensory neurons in the guinea-pig. , 1988, Pulmonary pharmacology.

[34]  A. Pack,et al.  Mechanisms for the association of gastroesophageal reflux and bronchospasm. , 1985, The American review of respiratory disease.

[35]  D. Cockcroft,et al.  Effect of pH on bronchial response to inhaled histamine. , 1982, Thorax.

[36]  H. Novey,et al.  Gastroesophageal reflux and asthma. , 1979, The Western journal of medicine.

[37]  C. L. Mendelson.  The aspiration of stomach contents into the lungs during obstetric anesthesia. , 1946, American journal of obstetrics and gynecology.